| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10915990 | Nuclear Medicine and Biology | 2014 | 7 Pages |
Abstract
There is diversity in evaluating antiangiogenic response when using 99mTc-3P-RGD2, which may be an important reminder in future clinical applications of RGD radiotracers as a strategy for antiangiogenesis therapy response monitoring.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Guangjie Yang, Hukui Sun, Yu Kong, Guihua Hou, Jiankui Han,